Skip to main content
ADNT $20.38 +1.75%
ADNT logo

ADNT · Adient plc

Track ADNT — free
$20.38 +0.35 (+1.75%)
Market Cap
$1.58B
Shares
77.10M
All earnings calls

Earnings call · FY2025 Q1

Adient plc Q1 FY2025 Earnings Call

Adient plc Q1 FY2025 Earnings Call

Concluded Jan 28, 2025
Jan 28, 2025 27 turns
Period
FY2025 Q1
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

China market dynamics and local OEM growth 41 Americas market and customer production 16 EMEA restructuring and demand headwinds 14 Operational performance and margin management 11 Tariff exposure and mitigation 11 Capital allocation and balance sheet 8

Management tone

Balanced

Net tone +12 · low hedging

Grounding quotes
  • “We are off to a solid start in fiscal 2025 with improved business performance compared to a year ago, allowing us to mitigate ongoing customer volume and mixed headwinds.”
  • “Our balance sheet remains strong with ample liquidity, including $860 million of cash on hand at the end of Q1.”
  • “Industry conditions remain challenging with strong production headwinds and program delays from economic and political uncertainty around electrification policies.”
  • “While near-term macro headwinds and customer mix pressures exist, Adient remains a supplier of choice with both domestic and Western OEs.”

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $3.50B -4.5% YoY
Diluted EPS $0.00 -100% YoY
Gross margin 6.2% -0.5 pp YoY
Net income $0 -100% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Americas Segment$1.61B -2.2% YoY
EMEA Segment$1.13B -11% YoY
Asia Segment$772.00M +0.3% YoY

Capital returned

Buybacks
$25.00M
Shares repurchased
1.23M
Full-screen source Call document